Skip to content

Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules

Ultrasound-guided Thermal Ablation for the Treatment of Benign Thyroid Nodules: A Multicenter Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06729762
Enrollment
1500
Registered
2024-12-11
Start date
2024-12-09
Completion date
2030-12-31
Last updated
2025-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Nodule (Benign)

Brief summary

To evaluate long-term outcomes of ultrasound-guided thermal ablation for benign thyroid nodules

Detailed description

To evaluate and predict long-term clinical outcomes of ultrasound-guided thermal ablation for benign thyroid nodules by a multicenter study

Interventions

radiofrequency ablation, microwave ablation, laser ablation

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. confirmation of benign nodule status on two separate fine- needle aspiration or core-needle biopsy 2. no suspicious malignant features on ultrasound examination 3. report of cosmetic and/ or symptomatic problems or concern of nodules growing rapidly or malignant transformation 4. refusal or ineligibility for surgery 5. follow-up time ≥12 months

Exclusion criteria

1. follicular neoplasm or malignancy findings on biopsy 2. nodules with benign result on biopsy had suspicious of malignancy in US 3. patients with contra-lateral vocal cord paralysis 4. previous radiation to the head and neck 5. follow- up time less than 12 months

Design outcomes

Primary

MeasureTime frameDescription
volume reduction ratethrough study completion, an average of 6 monthsThe volume reduction rate (VRR)was calculated by the equations: VRR=(\[initial volume-final volume\] × 100)/initial volume

Secondary

MeasureTime frameDescription
cosmetic scorethrough study completion, an average of 6 monthsThe cosmetic score was assessed by a physician (1, no palpable mass; 2, no cosmetic problem but palpable mass; 3, a cosmetic problem on swallowing only; and 4, a readily detected cosmetic problem)
symptom scorethrough study completion, an average of 6 monthsThe symptom score was self-measured by patients using a 10-cm visual analogue scale (grade 0-10)
rate of complications1 weekcomplications after ablation
rate of change of thyroid functionthrough study completion, an average of 6 monthsthyroid function test, including free triiodothyronine, free thyroxine, thyroid stimulating hormone, thyroid peroxidase antibody and anti-thyroglobulin antibodies
rate of disappearancethrough study completion, an average of 6 monthscomplete disappearance of ablated nodule on ultrasound and contrast-enhanced ultrasound
rate of nodule regrowththrough study completion, an average of 6 monthsRegrowth was defined as ≥50% volume increase compared to the previously recorded smallest volume during the follow-up

Countries

China

Contacts

Primary ContactLin Yan, MD
gemma-y@163.com13811237313

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026